What type of study is this?

This is a Quantitative Study study.

September 19, 2025Zeitschrift für Kristallographie - New Crystal StructuresOpen Access

Crystal structure of 4-((cyclohexylsulfonyl)methyl)-1,2,3,4-tetrahydrobenzo [4,5]imidazo[1,2-a]pyridine, C₁₈H₂₄N₂O₂S

View Full Paper

Ask AI

Bookmark

The crystal structure shows a monoclinic formation with a beta angle of 99.202°.
The compound's formula is C18H24N2O2S with a volume of 1653.86 Å³.
This structure determination has an R factor of 0.0586, suggesting reliability in the data.
Temperature during data collection was maintained at 100(1) K, ensuring stable conditions.

Implication

Analysis reveals crystal structure characteristics of a compound, indicating its monoclinic formation.

Abstract

C 18 H 24 N 2 O 2 S, monoclinic, P 2 1 / c (no. 14), a = 27.3975(7) Å, b = 6.16564(14) Å, c = 9.9182(2) Å, β = 99.202(2)°, V = 1653.86(7) Å 3 , Z = 4, R gt ( F ) = 0.0586, wR ref ( F 2 ) = 0.1544, T = 100(1) K.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68d464e031b076d99fa63d1c https://doi.org/10.1515/ncrs-2025-0311

View Full Paper

Ask AI

Bookmark

Implication

Analysis reveals crystal structure characteristics of a compound, indicating its monoclinic formation.

Crystal structure of 4-((cyclohexylsulfonyl)methyl)-1,2,3,4-tetrahydrobenzo [4,5]imidazo[1,2-a]pyridine, C₁₈H₂₄N₂O₂S

Key Points

Implication

Abstract

Discussion

Cite This Study

Crystal structure of 4-((cyclohexylsulfonyl)methyl)-1,2,3,4-tetrahydrobenzo [4,5]imidazo[1,2-a]pyridine, C₁₈H₂₄N₂O₂S

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading